Bancolombia S.A. (CIB) Market Value Rose While Polaris Capital Management Has Trimmed Its Stake by $40.04 Million; Fort LP Upped Gilead Sciences (GILD) Holding by $9.51 Million as Market Valuation Declined

January 14, 2018 - By Vivian Currie

Michael Novogratz increased its stake in Gilead Sciences Inc (GILD) by 92.25% based on its latest 2017Q3 regulatory filing with the SEC. Fort Lp bought 117,422 shares as the company’s stock declined 8.05% while stock markets rallied. The hedge fund run by Michael Novogratz held 244,713 shares of the health care company at the end of 2017Q3, valued at $19.83M, up from 127,291 at the end of the previous reported quarter. Fort Lp who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $103.22B market cap company. The stock decreased 0.05% or $0.04 during the last trading session, reaching $79.02. About 6.37M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since January 14, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Bernard Horn decreased its stake in Bancolombia S.A. (CIB) by 31.39% based on its latest 2017Q3 regulatory filing with the SEC. Polaris Capital Management Llc sold 889,800 shares as the company’s stock rose 18.47% with the market. The hedge fund run by Bernard Horn held 1.94M shares of the commercial banks company at the end of 2017Q3, valued at $89.05 million, down from 2.83M at the end of the previous reported quarter. Polaris Capital Management Llc who had been investing in Bancolombia S.A. for a number of months, seems to be less bullish one the $10.15B market cap company. The stock increased 1.21% or $0.51 during the last trading session, reaching $42.65. About 129,439 shares traded. Bancolombia S.A. (NYSE:CIB) has risen 27.44% since January 14, 2017 and is uptrending. It has outperformed by 10.74% the S&P500.

Polaris Capital Management Llc, which manages about $4.42 billion and $1.79 billion US Long portfolio, upped its stake in Web.Com Group Inc (NASDAQ:WWWW) by 143,500 shares to 1.74M shares, valued at $43.46M in 2017Q3, according to the filing. It also increased its holding in Carter’s Inc (NYSE:CRI) by 36,370 shares in the quarter, for a total of 379,621 shares, and has risen its stake in General Dynamics Corp. (NYSE:GD).

Among 11 analysts covering Bancolombia S.A. (NYSE:CIB), 1 have Buy rating, 4 Sell and 6 Hold. Therefore 9% are positive. Bancolombia S.A. had 22 analyst reports since July 23, 2015 according to SRatingsIntel. Deutsche Bank upgraded the shares of CIB in report on Monday, August 22 to “Buy” rating. The rating was downgraded by Citigroup on Tuesday, January 9 to “Sell”. The firm has “Hold” rating given on Friday, October 27 by Deutsche Bank. The firm has “Buy” rating by Zacks given on Monday, August 24. On Tuesday, December 13 the stock rating was upgraded by Morgan Stanley to “Overweight”. The stock has “Underweight” rating by Barclays Capital on Thursday, March 24. Standpoint Research upgraded Bancolombia S.A. (NYSE:CIB) rating on Friday, August 14. Standpoint Research has “Buy” rating and $48 target. The rating was upgraded by Standpoint Research to “Buy” on Monday, August 17. The firm has “Sell” rating by UBS given on Wednesday, March 16. The rating was downgraded by Credit Suisse on Thursday, October 6 to “Neutral”.

Analysts await Bancolombia S.A. (NYSE:CIB) to report earnings on February, 20. CIB’s profit will be $204.73M for 12.40 P/E if the $0.86 EPS becomes a reality. After $0.64 actual EPS reported by Bancolombia S.A. for the previous quarter, Wall Street now forecasts 34.38% EPS growth.

Fort Lp, which manages about $349.60 million and $406.56M US Long portfolio, decreased its stake in Taro Pharmaceutical Inds Ltd (NYSE:TARO) by 15,479 shares to 163,526 shares, valued at $18.43M in 2017Q3, according to the filing. It also reduced its holding in Block H & R Inc (NYSE:HRB) by 346,908 shares in the quarter, leaving it with 524,855 shares, and cut its stake in Humana Inc (NYSE:HUM).

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 18 have Buy rating, 0 Sell and 12 Hold. Therefore 60% are positive. Gilead Sciences had 111 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, February 12 by Maxim Group. The stock has “Buy” rating by UBS on Friday, April 29. The stock has “Buy” rating by Berenberg on Thursday, September 22. On Tuesday, July 25 the stock rating was maintained by Piper Jaffray with “Buy”. The rating was maintained by Morgan Stanley with “Equal-Weight” on Thursday, May 26. Mizuho initiated Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, November 8 with “Buy” rating. As per Wednesday, November 2, the company rating was upgraded by BMO Capital Markets. The rating was maintained by Jefferies on Wednesday, August 31 with “Hold”. The firm earned “Buy” rating on Monday, November 14 by Stifel Nicolaus. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Buy” rating by Maxim Group on Wednesday, October 28.

Since August 1, 2017, it had 0 insider buys, and 11 selling transactions for $41.13 million activity. 73,333 shares were sold by MARTIN JOHN C, worth $6.05 million on Monday, October 2. Meyers James R sold $4.99M worth of stock or 60,000 shares. The insider Washington Robin L sold 51,820 shares worth $4.40M.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.10, from 0.93 in 2017Q2. It is positive, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Cannell Peter B And Com owns 72,535 shares. United Svcs Automobile Association holds 1.37M shares. Bluestein R H Communication stated it has 0.01% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Alliancebernstein Lp stated it has 10.05 million shares or 0.61% of all its holdings. Davidson Invest has invested 2.86% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Zacks Inv owns 600,885 shares or 1.14% of their US portfolio. Wealth Enhancement Advisory Limited Liability Company holds 0.08% in Gilead Sciences, Inc. (NASDAQ:GILD) or 12,147 shares. 1,044 are held by Tci Wealth Advsr. Oregon Employees Retirement Fund accumulated 0.96% or 736,713 shares. Wealthtrust Axiom Ltd Limited Liability Company stated it has 0.61% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Norinchukin Retail Bank The has 0.26% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 164,025 shares. Natl Pension Ser owns 1.03M shares. Lpl Ltd Co reported 0.08% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Twin Mgmt Inc invested in 0.41% or 96,830 shares. Parkside Retail Bank & has 0.02% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 527 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com